0001235802-19-000141.txt : 20191223 0001235802-19-000141.hdr.sgml : 20191223 20191223161600 ACCESSION NUMBER: 0001235802-19-000141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191220 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andrews Julie CENTRAL INDEX KEY: 0001550508 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35065 FILM NUMBER: 191306241 MAIL ADDRESS: STREET 1: 5677 AIRLINE ROAD CITY: ARLINGTON STATE: TN ZIP: 38002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wright Medical Group N.V. CENTRAL INDEX KEY: 0001492658 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 980509600 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1229 BUSINESS ADDRESS: STREET 1: PRINS BERNHARDPLEIN 200 CITY: AMSTERDAM STATE: P7 ZIP: 1097JB BUSINESS PHONE: 901-867-4317 MAIL ADDRESS: STREET 1: 1023 CHERRY ROAD CITY: MEMPHIS STATE: TN ZIP: 38117 FORMER COMPANY: FORMER CONFORMED NAME: Tornier N.V. DATE OF NAME CHANGE: 20110201 FORMER COMPANY: FORMER CONFORMED NAME: Tornier B.V. DATE OF NAME CHANGE: 20100524 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-12-20 0 0001492658 Wright Medical Group N.V. WMGI 0001550508 Andrews Julie 1023 CHERRY ROAD MEMPHIS TN 38117 0 1 0 0 SVP, Global Finance Ordinary Shares, par value EUR 0.03 per share 2019-12-20 4 M 0 9000 19.36 A 41715 D Ordinary Shares, par value EUR 0.03 per share 2019-12-20 4 S 0 7001 30.0974 D 34714 D Stock Option (right to buy) 19.36 2019-12-20 4 M 0 9000 0 D 2022-05-18 Ordinary Shares 9000 11618 D Exercise and sale of vested stock options in connection with 280G tax planning under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.08 to $30.125, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. This option has fully vested. /s/ Marija Nelson, attorney-in-fact 2019-12-23